Category: Access campaign
MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
TB Day 2022: LIVE
MSF responds to UK’s disastrous proposal on intellectual property in UK-India Free Trade Agreement
Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the WTO
MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver
COVID-19: MSF urges governments to reject the draft COVID-19 text at WTO that would set a negative precedent
Tuberculosis: MSF responds to updated WHO guidelines for tuberculosis in children
